The Copenhagen Triage Algorithm is non-inferior to a traditional triage algorithm: A cluster-randomized study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Rasmus Bo Hasselbalch
  • Mia Pries-Heje
  • Martin Schultz
  • Louis Lind Plesner
  • Lisbet Ravn
  • Morten Lind
  • Rasmus Greibe
  • Birgitte Nybo Jensen
  • Thomas Høi-Hansen
  • Nicholas Carlson
  • Christian Torp-Pedersen
  • Lars S Rasmussen
  • Iversen, Kasper

INTRODUCTION: Triage systems with limited room for clinical judgment are used by emergency departments (EDs) worldwide. The Copenhagen Triage Algorithm (CTA) is a simplified triage system with a clinical assessment.

METHODS: The trial was a non-inferiority, two-center cluster-randomized crossover study where CTA was compared to a local adaptation of Adaptive Process Triage (ADAPT). CTA involves initial categorization based on vital signs with a final modification based on clinical assessment by an ED nurse. We used 30-day mortality with a non-inferiority margin at 0.5%. Predictive performance was compared using Receiver Operator Characteristics.

RESULTS: We included 45,347 patient visits, 23,158 (51%) and 22,189 (49%) were triaged with CTA and ADAPT respectively with a 30-day mortality of 3.42% and 3.43% (P = 0.996) a difference of 0.01% (95% CI: -0.34 to 0.33), which met the non-inferiority criteria. Mortality at 48 hours was 0.62% vs. 0.71%, (P = 0.26) and 6.38% vs. 6.61%, (P = 0.32) at 90 days for CTA and ADAPT. CTA triaged at significantly lower urgency level (P<0.001) and was superior in predicting 30-day mortality, Area under the curve: 0.67 (95% CI 0.65-0.69) compared to 0.64 for ADAPT (95% CI 0.62-0.66) (P = 0.03). There were no significant differences in rate of admission to the intensive care unit, length of stay, waiting time nor rate of readmission within 30 or 90 days.

CONCLUSION: A novel triage system based on vital signs and a clinical assessment by an ED nurse was non-inferior to a traditional triage algorithm by short term mortality, and superior in predicting 30-day mortality.

TRIAL REGISTRATION: Clinicaltrials.gov NCT02698319.

OriginalsprogEngelsk
Artikelnummere0211769
TidsskriftPLoS ONE
Vol/bind14
Udgave nummer2
Antal sider13
ISSN1932-6203
DOI
StatusUdgivet - 2019

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 224598803